13F Pro Quality Score

58.8/100

Rank #974 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

39.8/100

Profitability

42.9/100

Balance Sheet

62.9/100

Earnings Quality

80.2/100

Free Cash Flow

39.4/100

Institutional Flow

75.8/100

Revenue Scale

89.2/100

Dilution Risk

82.5/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

HSIC Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for HENRY SCHEIN INC (HSIC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HSIC at 58.8/100 on a 32-signal composite quality model, placing it at rank #974 of 2,961 stocks — the top half of the AI-ranked universe. HSIC scores in the top quartile across revenue scale (89.2), earnings quality (80.2), institutional flow (75.8). Areas of concern include free cash flow (39.4) and revenue growth (39.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), HENRY SCHEIN INC reports quarterly revenue of $3.5B, net income of $94.0M, an operating margin of 5.0%. Top institutional holders of HSIC by reported 13-F value include Kohlberg Kravis Roberts & L.P., FMR, BlackRock, based on the most recent SEC filings. HSIC trades on the Nasdaq exchange and files with the SEC under CIK 1000228. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HSIC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HENRY SCHEIN INC directly from SEC EDGAR. HENRY SCHEIN INC's 13F Pro composite quality score has ranged between 48 and 64 since 2021, currently 58.8 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

Fun facts about HENRY SCHEIN INC

Quirks, history, and lore behind HSIC — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. healthcare distribution company · mid-cap · listed on Nasdaq · headquartered on Long Island, New York.
  • 2
    The Numbers
    Annual revenue in the range of $12–13 billion, yet margins are thin — because the whole game is moving product efficiently to hundreds of thousands of small practices.
  • 3
    The History
    Founded in 1932 as a small dental supply shop, it spent decades building one of the largest direct-to-practitioner distribution networks in healthcare.
  • 4
    The Secret
    It doesn't just sell supplies — it also provides practice management software and technology solutions, making it sticky with the independent doctors and dentists it serves.
  • 5
    The Lore
    It serves over one million healthcare practitioners across more than 30 countries, making it a quiet giant that keeps your dentist's drill stocked and their billing software humming.
  • 6
    The Giveaway
    If your dentist, veterinarian, or doctor is in a small or mid-size practice, odds are high their dental chairs, syringes, and office software came from this Long Island distributor with a very distinguished-sounding name.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$3.5B

Net Income

Q2 2026

$94.0M

Free Cash Flow

Q2 2026

$212.0M

Operating Margin

Q2 2026

5.0%

ROIC

Q2 2026

10.3%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+4.0% YoY
$13.18BFY 2025
FY22 $12.65BFY23 $12.34BFY24 $12.67BFY25 $13.18B

Net Income

+2.1% YoY
$398.0MFY 2025
FY22 $538.0MFY23 $416.0MFY24 $390.0MFY25 $398.0M

Operating Income

+5.2% YoY
$653.0MFY 2025
FY22 $747.0MFY23 $615.0MFY24 $621.0MFY25 $653.0M

EPS (Diluted)

+7.2% YoY
$3.27FY 2025
FY22 $3.91FY23 $3.16FY24 $3.05FY25 $3.27

Total Assets

+9.8% YoY
$11.21BFY 2025
FY22 $8.61BFY23 $10.57BFY24 $10.22BFY25 $11.21B

Total Debt

+22.5% YoY
$3.11BFY 2025
FY22 $1.16BFY23 $2.35BFY24 $2.54BFY25 $3.11B

Op. Cash Flow

-16.0% YoY
$712.0MFY 2025
FY22 $602.0MFY23 $500.0MFY24 $848.0MFY25 $712.0M

Free Cash Flow

-18.1% YoY
$573.0MFY 2025
FY22 $506.0MFY23 $353.0MFY24 $700.0MFY25 $573.0M

Get alerted when HSIC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HENRY SCHEIN INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of HSIC

Companies Similar to HSIC

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

GEHC

GE HealthCare Technologies Inc.

57
AI score
Similar quality profile · 15 shared holders
UHS

UNIVERSAL HEALTH SERVICES INC

66
AI score
Similar quality profile · 15 shared holders
DVA

DAVITA INC.

62
AI score
Similar quality profile · 17 shared holders
DGX

QUEST DIAGNOSTICS INC

69
AI score
Similar quality profile · 18 shared holders
CVS

CVS HEALTH Corp

64
AI score
Similar quality profile · 15 shared holders
LH

LABCORP HOLDINGS INC.

64
AI score
Similar quality profile · 14 shared holders
ZBH

ZIMMER BIOMET HOLDINGS, INC.

64
AI score
Similar quality profile · 19 shared holders
IQV

IQVIA HOLDINGS INC.

64
AI score
Similar quality profile · 15 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put HSIC on your watchlist

Track score changes the day HENRY SCHEIN INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HSIC a good stock to buy?

13F Pro's AI-powered analysis of HENRY SCHEIN INC (HSIC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HSIC are available on the HSIC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. HSIC is classified as a mid company.

Which hedge funds own HSIC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HSIC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HENRY SCHEIN INC's investment landscape.